Trial intelligence / Profile preview

Advagraf conversion in stable kidney transplant patients

NCT00384137Phase 3Completed

Sponsor
Astellas Pharma
Start
Oct 2006
Primary completion
Jul 2007
Modality
RNA-Targeting Small Molecules
Countries
6
01

Overview

A Phase 3 trial of tacrolimus in kidney transplantation, sponsored by Astellas Pharma. Started Oct 2006; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT00384137.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00384137.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call